ncoa1 Search Results


anti src1  (Bioss)
91
Bioss anti src1
Anti Src1, supplied by Bioss, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ncoa1/pmc08390517-293-43-44?v=Bioss
Average 91 stars, based on 1 article reviews
anti src1 - by Bioz Stars, 2026-07
91/100 stars
  Buy from Supplier
src 1 antibody  (Proteintech)
93
Proteintech src 1 antibody
a COS-1 were transfected with a Gal4 luciferase reporter and β-galactosidase expression plasmid, expression plasmids for Gal4 fused full-length of truncations of FUS and p300, SRC1 or ARA70. b COS-1 were transfected with plasmids encoding the AR, <t>SRC-1,</t> FUS and β-galactosidase, and an AR-responsive luciferase reporter. Luciferase activity was expressed as a % of AR activity in the presence of mibolerone (MIB) and absence of SRC1 and FUS. Mean ± 1SE of 3 independent repeats in duplicate. c Immunoblotting was performed to confirm successful expression of the AR, SRC1 and FUS. d LNCaP FUS were treated ± MIB ± DOX and chromatin immunoprecipitation performed using antibodies specific to the AR, SRC1, RNA Pol II, FUS, or IgG control. Enrichment of the KLK3 enhancer was analysed using qPCR. Mean ± 1SE of 3 independent repeats. ANOVA * p < 0.05, ** p < 0.005, *** p < 0.0005.
Src 1 Antibody, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ncoa1/pmc12909129-79-26-31?v=Proteintech
Average 93 stars, based on 1 article reviews
src 1 antibody - by Bioz Stars, 2026-07
93/100 stars
  Buy from Supplier
c terminal flag myc tag  (OriGene)
90
OriGene c terminal flag myc tag
a COS-1 were transfected with a Gal4 luciferase reporter and β-galactosidase expression plasmid, expression plasmids for Gal4 fused full-length of truncations of FUS and p300, SRC1 or ARA70. b COS-1 were transfected with plasmids encoding the AR, <t>SRC-1,</t> FUS and β-galactosidase, and an AR-responsive luciferase reporter. Luciferase activity was expressed as a % of AR activity in the presence of mibolerone (MIB) and absence of SRC1 and FUS. Mean ± 1SE of 3 independent repeats in duplicate. c Immunoblotting was performed to confirm successful expression of the AR, SRC1 and FUS. d LNCaP FUS were treated ± MIB ± DOX and chromatin immunoprecipitation performed using antibodies specific to the AR, SRC1, RNA Pol II, FUS, or IgG control. Enrichment of the KLK3 enhancer was analysed using qPCR. Mean ± 1SE of 3 independent repeats. ANOVA * p < 0.05, ** p < 0.005, *** p < 0.0005.
C Terminal Flag Myc Tag, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ncoa1/pm30979869-267-14-21?v=OriGene
Average 90 stars, based on 1 article reviews
c terminal flag myc tag - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
src 1  (OriGene)
90
OriGene src 1
a COS-1 were transfected with a Gal4 luciferase reporter and β-galactosidase expression plasmid, expression plasmids for Gal4 fused full-length of truncations of FUS and p300, SRC1 or ARA70. b COS-1 were transfected with plasmids encoding the AR, <t>SRC-1,</t> FUS and β-galactosidase, and an AR-responsive luciferase reporter. Luciferase activity was expressed as a % of AR activity in the presence of mibolerone (MIB) and absence of SRC1 and FUS. Mean ± 1SE of 3 independent repeats in duplicate. c Immunoblotting was performed to confirm successful expression of the AR, SRC1 and FUS. d LNCaP FUS were treated ± MIB ± DOX and chromatin immunoprecipitation performed using antibodies specific to the AR, SRC1, RNA Pol II, FUS, or IgG control. Enrichment of the KLK3 enhancer was analysed using qPCR. Mean ± 1SE of 3 independent repeats. ANOVA * p < 0.05, ** p < 0.005, *** p < 0.0005.
Src 1, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ncoa1/pmc03307100-102-13-32?v=OriGene
Average 90 stars, based on 1 article reviews
src 1 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
gene exp ncoa1 mm00447958 m1  (Thermo Fisher)
86
Thermo Fisher gene exp ncoa1 mm00447958 m1
a COS-1 were transfected with a Gal4 luciferase reporter and β-galactosidase expression plasmid, expression plasmids for Gal4 fused full-length of truncations of FUS and p300, SRC1 or ARA70. b COS-1 were transfected with plasmids encoding the AR, <t>SRC-1,</t> FUS and β-galactosidase, and an AR-responsive luciferase reporter. Luciferase activity was expressed as a % of AR activity in the presence of mibolerone (MIB) and absence of SRC1 and FUS. Mean ± 1SE of 3 independent repeats in duplicate. c Immunoblotting was performed to confirm successful expression of the AR, SRC1 and FUS. d LNCaP FUS were treated ± MIB ± DOX and chromatin immunoprecipitation performed using antibodies specific to the AR, SRC1, RNA Pol II, FUS, or IgG control. Enrichment of the KLK3 enhancer was analysed using qPCR. Mean ± 1SE of 3 independent repeats. ANOVA * p < 0.05, ** p < 0.005, *** p < 0.0005.
Gene Exp Ncoa1 Mm00447958 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ncoa1/pm20501672-77-21-37?v=Thermo+Fisher
Average 86 stars, based on 1 article reviews
gene exp ncoa1 mm00447958 m1 - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier
anti ncoa1  (Boster Bio)
91
Boster Bio anti ncoa1
a COS-1 were transfected with a Gal4 luciferase reporter and β-galactosidase expression plasmid, expression plasmids for Gal4 fused full-length of truncations of FUS and p300, SRC1 or ARA70. b COS-1 were transfected with plasmids encoding the AR, <t>SRC-1,</t> FUS and β-galactosidase, and an AR-responsive luciferase reporter. Luciferase activity was expressed as a % of AR activity in the presence of mibolerone (MIB) and absence of SRC1 and FUS. Mean ± 1SE of 3 independent repeats in duplicate. c Immunoblotting was performed to confirm successful expression of the AR, SRC1 and FUS. d LNCaP FUS were treated ± MIB ± DOX and chromatin immunoprecipitation performed using antibodies specific to the AR, SRC1, RNA Pol II, FUS, or IgG control. Enrichment of the KLK3 enhancer was analysed using qPCR. Mean ± 1SE of 3 independent repeats. ANOVA * p < 0.05, ** p < 0.005, *** p < 0.0005.
Anti Ncoa1, supplied by Boster Bio, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ncoa1/pm36399857-96-18-29?v=Boster+Bio
Average 91 stars, based on 1 article reviews
anti ncoa1 - by Bioz Stars, 2026-07
91/100 stars
  Buy from Supplier
nuclear receptor coactivator1 peptide (ncoa1-ii peptide)  (GenScript corporation)
90
GenScript corporation nuclear receptor coactivator1 peptide (ncoa1-ii peptide)
a COS-1 were transfected with a Gal4 luciferase reporter and β-galactosidase expression plasmid, expression plasmids for Gal4 fused full-length of truncations of FUS and p300, SRC1 or ARA70. b COS-1 were transfected with plasmids encoding the AR, <t>SRC-1,</t> FUS and β-galactosidase, and an AR-responsive luciferase reporter. Luciferase activity was expressed as a % of AR activity in the presence of mibolerone (MIB) and absence of SRC1 and FUS. Mean ± 1SE of 3 independent repeats in duplicate. c Immunoblotting was performed to confirm successful expression of the AR, SRC1 and FUS. d LNCaP FUS were treated ± MIB ± DOX and chromatin immunoprecipitation performed using antibodies specific to the AR, SRC1, RNA Pol II, FUS, or IgG control. Enrichment of the KLK3 enhancer was analysed using qPCR. Mean ± 1SE of 3 independent repeats. ANOVA * p < 0.05, ** p < 0.005, *** p < 0.0005.
Nuclear Receptor Coactivator1 Peptide (Ncoa1 Ii Peptide), supplied by GenScript corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ncoa1/pmc09060471__pnas__2023784119__sapp-86-1-26?v=GenScript+corporation
Average 90 stars, based on 1 article reviews
nuclear receptor coactivator1 peptide (ncoa1-ii peptide) - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
stapled peptide targeting the ncoa1/stat6 protein-protein interaction  (POSTECH Inc)
90
POSTECH Inc stapled peptide targeting the ncoa1/stat6 protein-protein interaction
a COS-1 were transfected with a Gal4 luciferase reporter and β-galactosidase expression plasmid, expression plasmids for Gal4 fused full-length of truncations of FUS and p300, SRC1 or ARA70. b COS-1 were transfected with plasmids encoding the AR, <t>SRC-1,</t> FUS and β-galactosidase, and an AR-responsive luciferase reporter. Luciferase activity was expressed as a % of AR activity in the presence of mibolerone (MIB) and absence of SRC1 and FUS. Mean ± 1SE of 3 independent repeats in duplicate. c Immunoblotting was performed to confirm successful expression of the AR, SRC1 and FUS. d LNCaP FUS were treated ± MIB ± DOX and chromatin immunoprecipitation performed using antibodies specific to the AR, SRC1, RNA Pol II, FUS, or IgG control. Enrichment of the KLK3 enhancer was analysed using qPCR. Mean ± 1SE of 3 independent repeats. ANOVA * p < 0.05, ** p < 0.005, *** p < 0.0005.
Stapled Peptide Targeting The Ncoa1/Stat6 Protein Protein Interaction, supplied by POSTECH Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ncoa1/10__1002_slash_psc__3127-5224-3-22?v=POSTECH+Inc
Average 90 stars, based on 1 article reviews
stapled peptide targeting the ncoa1/stat6 protein-protein interaction - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
peptide ncoa1 (lxd4)  (Bachem)
90
Bachem peptide ncoa1 (lxd4)
a COS-1 were transfected with a Gal4 luciferase reporter and β-galactosidase expression plasmid, expression plasmids for Gal4 fused full-length of truncations of FUS and p300, SRC1 or ARA70. b COS-1 were transfected with plasmids encoding the AR, <t>SRC-1,</t> FUS and β-galactosidase, and an AR-responsive luciferase reporter. Luciferase activity was expressed as a % of AR activity in the presence of mibolerone (MIB) and absence of SRC1 and FUS. Mean ± 1SE of 3 independent repeats in duplicate. c Immunoblotting was performed to confirm successful expression of the AR, SRC1 and FUS. d LNCaP FUS were treated ± MIB ± DOX and chromatin immunoprecipitation performed using antibodies specific to the AR, SRC1, RNA Pol II, FUS, or IgG control. Enrichment of the KLK3 enhancer was analysed using qPCR. Mean ± 1SE of 3 independent repeats. ANOVA * p < 0.05, ** p < 0.005, *** p < 0.0005.
Peptide Ncoa1 (Lxd4), supplied by Bachem, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ncoa1/pm31375639-57-7-6?v=Bachem
Average 90 stars, based on 1 article reviews
peptide ncoa1 (lxd4) - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier
taqman gene expression assays for ncoa1 (hs00186661_m1)  (Thermo Fisher)
88
Thermo Fisher taqman gene expression assays for ncoa1 (hs00186661_m1)
a COS-1 were transfected with a Gal4 luciferase reporter and β-galactosidase expression plasmid, expression plasmids for Gal4 fused full-length of truncations of FUS and p300, SRC1 or ARA70. b COS-1 were transfected with plasmids encoding the AR, <t>SRC-1,</t> FUS and β-galactosidase, and an AR-responsive luciferase reporter. Luciferase activity was expressed as a % of AR activity in the presence of mibolerone (MIB) and absence of SRC1 and FUS. Mean ± 1SE of 3 independent repeats in duplicate. c Immunoblotting was performed to confirm successful expression of the AR, SRC1 and FUS. d LNCaP FUS were treated ± MIB ± DOX and chromatin immunoprecipitation performed using antibodies specific to the AR, SRC1, RNA Pol II, FUS, or IgG control. Enrichment of the KLK3 enhancer was analysed using qPCR. Mean ± 1SE of 3 independent repeats. ANOVA * p < 0.05, ** p < 0.005, *** p < 0.0005.
Taqman Gene Expression Assays For Ncoa1 (Hs00186661 M1), supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ncoa1/10__1530_slash_erc___16___0160-55-6-40?v=Thermo+Fisher
Average 88 stars, based on 1 article reviews
taqman gene expression assays for ncoa1 (hs00186661_m1) - by Bioz Stars, 2026-07
88/100 stars
  Buy from Supplier
gene exp ncoa1 mm01318933 m1  (Thermo Fisher)
88
Thermo Fisher gene exp ncoa1 mm01318933 m1
a COS-1 were transfected with a Gal4 luciferase reporter and β-galactosidase expression plasmid, expression plasmids for Gal4 fused full-length of truncations of FUS and p300, SRC1 or ARA70. b COS-1 were transfected with plasmids encoding the AR, <t>SRC-1,</t> FUS and β-galactosidase, and an AR-responsive luciferase reporter. Luciferase activity was expressed as a % of AR activity in the presence of mibolerone (MIB) and absence of SRC1 and FUS. Mean ± 1SE of 3 independent repeats in duplicate. c Immunoblotting was performed to confirm successful expression of the AR, SRC1 and FUS. d LNCaP FUS were treated ± MIB ± DOX and chromatin immunoprecipitation performed using antibodies specific to the AR, SRC1, RNA Pol II, FUS, or IgG control. Enrichment of the KLK3 enhancer was analysed using qPCR. Mean ± 1SE of 3 independent repeats. ANOVA * p < 0.05, ** p < 0.005, *** p < 0.0005.
Gene Exp Ncoa1 Mm01318933 M1, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 88/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ncoa1/10__2139_slash_ssrn__3586657-328-44--1?v=Thermo+Fisher
Average 88 stars, based on 1 article reviews
gene exp ncoa1 mm01318933 m1 - by Bioz Stars, 2026-07
88/100 stars
  Buy from Supplier
pcmv6 xl4 ncoa1  (OriGene)
90
OriGene pcmv6 xl4 ncoa1
a COS-1 were transfected with a Gal4 luciferase reporter and β-galactosidase expression plasmid, expression plasmids for Gal4 fused full-length of truncations of FUS and p300, SRC1 or ARA70. b COS-1 were transfected with plasmids encoding the AR, <t>SRC-1,</t> FUS and β-galactosidase, and an AR-responsive luciferase reporter. Luciferase activity was expressed as a % of AR activity in the presence of mibolerone (MIB) and absence of SRC1 and FUS. Mean ± 1SE of 3 independent repeats in duplicate. c Immunoblotting was performed to confirm successful expression of the AR, SRC1 and FUS. d LNCaP FUS were treated ± MIB ± DOX and chromatin immunoprecipitation performed using antibodies specific to the AR, SRC1, RNA Pol II, FUS, or IgG control. Enrichment of the KLK3 enhancer was analysed using qPCR. Mean ± 1SE of 3 independent repeats. ANOVA * p < 0.05, ** p < 0.005, *** p < 0.0005.
Pcmv6 Xl4 Ncoa1, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/ncoa1/pm21131266-56-21-22?v=OriGene
Average 90 stars, based on 1 article reviews
pcmv6 xl4 ncoa1 - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


a COS-1 were transfected with a Gal4 luciferase reporter and β-galactosidase expression plasmid, expression plasmids for Gal4 fused full-length of truncations of FUS and p300, SRC1 or ARA70. b COS-1 were transfected with plasmids encoding the AR, SRC-1, FUS and β-galactosidase, and an AR-responsive luciferase reporter. Luciferase activity was expressed as a % of AR activity in the presence of mibolerone (MIB) and absence of SRC1 and FUS. Mean ± 1SE of 3 independent repeats in duplicate. c Immunoblotting was performed to confirm successful expression of the AR, SRC1 and FUS. d LNCaP FUS were treated ± MIB ± DOX and chromatin immunoprecipitation performed using antibodies specific to the AR, SRC1, RNA Pol II, FUS, or IgG control. Enrichment of the KLK3 enhancer was analysed using qPCR. Mean ± 1SE of 3 independent repeats. ANOVA * p < 0.05, ** p < 0.005, *** p < 0.0005.

Journal: Oncogene

Article Title: Disruption of androgen receptor-cofactor interactions by the RNA-binding protein FUS/TLS alters androgen signalling in prostate cancer

doi: 10.1038/s41388-026-03682-3

Figure Lengend Snippet: a COS-1 were transfected with a Gal4 luciferase reporter and β-galactosidase expression plasmid, expression plasmids for Gal4 fused full-length of truncations of FUS and p300, SRC1 or ARA70. b COS-1 were transfected with plasmids encoding the AR, SRC-1, FUS and β-galactosidase, and an AR-responsive luciferase reporter. Luciferase activity was expressed as a % of AR activity in the presence of mibolerone (MIB) and absence of SRC1 and FUS. Mean ± 1SE of 3 independent repeats in duplicate. c Immunoblotting was performed to confirm successful expression of the AR, SRC1 and FUS. d LNCaP FUS were treated ± MIB ± DOX and chromatin immunoprecipitation performed using antibodies specific to the AR, SRC1, RNA Pol II, FUS, or IgG control. Enrichment of the KLK3 enhancer was analysed using qPCR. Mean ± 1SE of 3 independent repeats. ANOVA * p < 0.05, ** p < 0.005, *** p < 0.0005.

Article Snippet: Immunoblotting was performed as previously described [ ] using the following primary antibodies: AR (N-20), FUS (4H11), EWS (G-5) antibodies were from Santa Cruz (CA, USA), SRC-1 antibody (21952-1-AP) was from Proteintech (IL, USA).

Techniques: Transfection, Luciferase, Expressing, Plasmid Preparation, Activity Assay, Western Blot, Chromatin Immunoprecipitation, Control